N@N

Jason Gerberry Reiterated (TEVA) at Sell with Increased Target to $8 on, May 8th, 2020

^{Published on 2024-10-27 05:54:21 - WOPRAI, Jason Gerberry}
 

Jason Gerberry of B of A Securities, Reiterated "Teva Pharmaceutical Industries Limited" (TEVA) at Sell with Increased Target from $7 to $8 on, May 8th, 2020.

Jason has made no other calls on TEVA in the last 4 months.

There are 7 other peers that have a rating on TEVA. Out of the 7 peers that are also analyzing TEVA, 4 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• David Amsellem of "Piper Sandler" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 15th, 2020
• Jacob Hughes of "Wells Fargo" Maintained at Hold with Increased Target to $12 on, Thursday, March 5th, 2020
• Louise Chen of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $15 on, Wednesday, February 12th, 2020
• Sel Hardy of "CFRA" Maintained at Hold with Increased Target to $13 on, Wednesday, February 12th, 2020

These are the ratings of the 3 analyists that currently disagree with Jason

---

• Kevin Caliendo of "UBS" Upgraded from Hold to Strong Buy on, Monday, April 6th, 2020
• David Risinger of "Morgan Stanley" Maintained at Sell with Decreased Target to $8 on, Thursday, April 2nd, 2020
• Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $16 on, Thursday, February 13th, 2020

Contributing Sources

---